CORRESP Filing
Stoke Therapeutics, Inc.
Date: July 9, 2025 · CIK: 0001623526 · Accession: 0001193125-25-157116
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288583
Letter
Re:
STOKE THERAPEUTICS, INC. 45 Wiggins Avenue Bedford, MA 01730 July 9, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Office of Life Sciences
Stoke Therapeutics, Inc. Registration Statement on Form S-3 Filed July 9, 2025 File No. 333-288583 Via EDGAR - Acceleration Request
Requested Date:
July 11, 2025
Requested Time:
4:00 p.m. Eastern Time Ladies and Gentlemen: Stoke Therapeutics, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Registrant hereby authorizes Robert A. Freedman or Julia Forbess, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Forbess at (415) 875-2420 or, in her absence, to Mr. Freedman at (206) 389-4524. * * *
Sincerely,
S TOKE T HERAPEUTICS , I NC .
Show Raw Text
CORRESP 1 filename1.htm CORRESP STOKE THERAPEUTICS, INC. 45 Wiggins Avenue Bedford, MA 01730 July 9, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Office of Life Sciences Re: Stoke Therapeutics, Inc. Registration Statement on Form S-3 Filed July 9, 2025 File No. 333-288583 Via EDGAR - Acceleration Request Requested Date: July 11, 2025 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Stoke Therapeutics, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Registrant hereby authorizes Robert A. Freedman or Julia Forbess, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Forbess at (415) 875-2420 or, in her absence, to Mr. Freedman at (206) 389-4524. * * * Sincerely, S TOKE T HERAPEUTICS , I NC . By: /s/ Thomas Leggett Thomas Leggett Chief Financial Officer cc: Ian F. Smith, Interim Chief Executive Officer Jonathan Allan, General Counsel Stoke Therapeutics, Inc. Robert A. Freedman, Esq. Julia Forbess, Esq. Fenwick & West LLP